These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 36007560)
21. On the role of salt formation and structural similarity of co-formers in co-amorphous drug delivery systems. Wu W; Löbmann K; Rades T; Grohganz H Int J Pharm; 2018 Jan; 535(1-2):86-94. PubMed ID: 29102703 [TBL] [Abstract][Full Text] [Related]
22. Co-Amorphous Formulations of Furosemide with Arginine and P-Glycoprotein Inhibitor Drugs. Ruponen M; Kettunen K; Santiago Pires M; Laitinen R Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33514009 [TBL] [Abstract][Full Text] [Related]
23. Characterization of co-amorphous carvedilol-maleic acid system prepared by solvent evaporation. Furuishi T; Sato-Hata N; Fukuzawa K; Yonemochi E Pharm Dev Technol; 2023; 28(3-4):309-317. PubMed ID: 36946594 [TBL] [Abstract][Full Text] [Related]
24. Cocrystals, Salts, and Salt-Solvates of olanzapine; selection of coformers and improved solubility. Gong W; Mondal PK; Ahmadi S; Wu Y; Rohani S Int J Pharm; 2021 Oct; 608():121063. PubMed ID: 34481007 [TBL] [Abstract][Full Text] [Related]
25. Nucleotides as new co-formers in co-amorphous systems: Enhanced dissolution rate, water solubility and physical stability. Liu X; Shen L; Zhou L; Wu W; Liang G; Zhao Y; Wu W Eur J Pharm Biopharm; 2024 Jul; 200():114333. PubMed ID: 38768766 [TBL] [Abstract][Full Text] [Related]
26. New Saccharin Salt of Chlordiazepoxide: Structural and Physicochemical Examination. Lech A; Garbacz P; Sikorski A; Gazda M; Wesolowski M Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233346 [TBL] [Abstract][Full Text] [Related]
27. Co-Amorphous Formation of High-Dose Zwitterionic Compounds with Amino Acids To Improve Solubility and Enable Parenteral Delivery. Zhu S; Gao H; Babu S; Garad S Mol Pharm; 2018 Jan; 15(1):97-107. PubMed ID: 29164901 [TBL] [Abstract][Full Text] [Related]
28. Co-amorphous palbociclib-organic acid systems with increased dissolution rate, enhanced physical stability and equivalent biosafety. Zhang M; Xiong X; Suo Z; Hou Q; Gan N; Tang P; Ding X; Li H RSC Adv; 2019 Jan; 9(7):3946-3955. PubMed ID: 35518078 [TBL] [Abstract][Full Text] [Related]
29. Downstream Processing of Amorphous and Co-Amorphous Olanzapine Powder Blends. da Costa NF; Daniels R; Fernandes AI; Pinto JF Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893791 [TBL] [Abstract][Full Text] [Related]